Gentamicin-resistance plasmids in an intensive care unit

Insights

Plasmids contribute to antibiotic resistance in Enterobacteriaceae. This study found specific R-plasmids spread, potentially explaining gentamicin resistance in hospital intensive care units.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Antibiotic resistance in Enterobacteriaceae is a significant healthcare concern.
  • Plasmids are known to play a role in the dissemination of antibiotic resistance.
  • Understanding resistance mechanisms in intensive care units is crucial.

Purpose of the Study:

  • To investigate the role of plasmids in endemic antibiotic resistance among Enterobacteriaceae.
  • To identify the prevalence and characteristics of gentamicin-resistant gram-negative bacilli (GRGNB) in a medical/coronary care unit.
  • To determine if plasmid spread contributes to antibiotic resistance dissemination within the unit.

Main Methods:

  • Prospective study involving culture surveys of patients, staff, and environment.
  • Sampling of new admissions and ongoing monitoring throughout their stay.
  • Isolation and characterization of GRGNB, including plasmid analysis via restriction endonuclease digestion and conjugation/transformation experiments.

Main Results:

  • 12% of patients (147 total) were colonized with 20 strains of GRGNB.
  • 7 of 24 GRGNB strains (29%) were Enterobacteriaceae carrying plasmids with gentamicin-resistance determinants.
  • Identical plasmids (93 kb and 60 kb) were found in different bacterial species and environments within the hospital, indicating spread.

Conclusions:

  • Specific R-plasmids are implicated in the dissemination of gentamicin resistance in this intensive care unit.
  • The spread of plasmids like the 93 kb and 60 kb plasmids likely contributes to endemic antibiotic resistance.
  • This highlights the importance of monitoring plasmid dynamics in healthcare settings to control resistance.

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...